Ebola virus disease (EVD) is a viral hemorrhagic fever with a high case-fatality rate in humans. 35 EVD is caused by four members of the filoviral genus Ebolavirus, with Ebola virus (EBOV) 36 being the most notorious one. Although bats are discussed as potential ebolavirus reservoirs, 37 limited data actually support this hypothesis. Glycoprotein 2 (GP2) of reptarenaviruses, known to 38 infect only boa constrictors and pythons, are similar in sequence and structure to ebolaviral 39 glycoprotein 2 (GP 2 ), suggesting that EBOV may be able to infect snake cells. We therefore 40 serially passaged EBOV and a distantly related filovirus, Marburg virus (MARV), in the boa 41 constrictor kidney cell line, JK, and characterized viral growth and mutational frequency by 42 sequencing. We observed that EBOV efficiently infected and replicated in JK cells, but MARV 43 did not. In contrast to most cell lines, EBOV infected JK cells did not result in obvious 44 cytopathic effect (CPE). Genomic characterization of serial-passaged EBOV in JK cells revealed 45 that genomic adaptation was not required for infection. Deep sequencing coverage (>10,000x) 46
demonstrated the existence of only a single non-synonymous variant (EBOV glycoprotein 47 precursor preGP T544I) of unknown significance within the viral population that exhibited a 48 shift in frequency of at least 10% over six passages. Our data suggest that boid snake derived 49 cells are competent for filovirus infection without appreciable genomic adaptation; that cellular 50 filovirus infection without CPE may be more common than currently appreciated; and that there 51 may be significant differences between the natural host spectra of ebolaviruses and 52
marburgviruses. 53

INTRODUCTION 64
Ebola virus (EBOV) is one of five members of the genus Ebolavirus in the mononegaviral 65 family Filoviridae. Four ebolaviruses (Bundibugyo virus, EBOV, Sudan virus, Taï Forest virus) 66 are known to cause Ebola virus disease (EVD), whereas the fifth member, Reston virus 67 (RESTV), is thought to be nonpathogenic for humans. EVD is clinically indistinguishable from 68 HeLa cells were plated in six-well plates (at 300,000 cells/well, three replicates per cell line per 131 virus). One day later, cells were exposed to EBOV or MARV at a multiplicity of infection (MOI) 132 of 1. Briefly, exposure was performed by first removing media from cells, incubating cells with 133 media containing filovirus for 1 h, washing cells, and finally adding fresh media back to cells. 134
Infected cells were then incubated at 37°C in a 5% CO 2 atmosphere for 3 or 4 days (Fig. 1) . 135
Supernatants were collected at the indicated time points; 50 µl were used to infect monolayers of 136 fresh cells; and 1.5 ml were added to Trizol for sequencing. 137
Filovirus immunostaining 138
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Cells infected with EBOV or MARV were stained for high-content quantitative image-based 139 analysis with murine monoclonal antibodies against EBOV or MARV GP 1 , 2 (6D8 and 9G4 140 antibody, respectively), followed by Alexa Fluor 488-conjugated goat anti-mouse IgG 141 (Invitrogen, Thermo Fisher Scientific, Waltham, MA USA). Infected cells were also stained with 142
Hoechst 33342 and HCS CellMask Red (Invitrogen, Thermo Fisher Scientific, Waltham, MA 143 USA) for nuclei and cytoplasm detection, respectively. Infection rates and cell numbers were 144 determined using high-content quantitative imaging data on an Opera quadruple excitation high 145 sensitivity confocal reader (model 3842 and 5025; PerkinElmer, Waltham, MA USA) at two 146 exposures using ×10 air, ×20 water, or ×40 water objective lenses as described in (24) . Analysis 147 of the images was accomplished within the Opera environment using standard Acapella scripts. 148
At least 4,000 cells and up to 9,000 cells, were analyzed per well. 149
Measurement of Cytopathic effects 150
We measured cell number as an indication of CPE. See Filovirus immunostaining methods for 151 details. Briefly, infected cells were also stained with Hoechst 33342 and HCS CellMask Red 152 (Invitrogen, Thermo Fisher Scientific, Waltham, MA USA) for nuclei and cytoplasm detection, 153 respectively. Infection rates and cell numbers were determined using high-content quantitative 154 imaging data on an Opera quadruple excitation high sensitivity confocal reader. 155
Passage population size measurement 156
The number of EBOV genomes that each passage produced and the number of genomes added to 157 sequencing libraries were determined by two-step reverse transcription droplet digital PCR (RT-158 ddPCR) (25). EBOV RNA was reverse-transcribed using EBOV-specific primer EBOGP_For 159 (TGGGCTGAAAACTGCTACAATC), diluted, and assayed with the Bio-Rad Qx200 Droplet 160
Digital PCR System (Bio-Rad, Hercules, CA USA) following the manufacturer's instructions.
Sequencing-library preparations 162
Trizol inactivated samples were prepared for Illumina sequencing using a protocol slightly-163 modified from our previously published protocol (26) Briefly, complementary DNA (cDNA) 164 was created from randomly primed RNA using SuperScript VILO Master Mix (Thermo Fisher 165 Scientific, Waltham, MA USA). cDNA was tagmented using Illumina's Nextera reagents 166 (Illumina, San Diego, CA, USA), followed by dual-barcoding to prevent miscalling of samples 167 (27). Libraries were quantified by qPCR, pooled, size-selected using BluePippin (Sage Science, 168
Beverly, MA, USA), amplified, quantified again by qPCR, and paired-end sequenced (150/150 169 bases) on an Illumina HiSeq 4000 system at the University of California, San Francisco Center 170 for Advanced Technology. Samples HeLa-P1-R1 (Host-Passage-Replicate) and JK-P1-R1 171 through JK-P6-R1 were prepared and sequenced separately using the same method and 172
sequencer. 173
Single nucleotide variant analysis pipeline 174
Sequencing reads were filtered for reads containing sequencing adapters and quality using a cut-175 off of at least 95% of the sequence having a 0.98 probability being correct (-rqf 95 0.98) with 176
PriceSeqFilter from PRICE (version 1.2) (28). Filtered reads were aligned to the EBOV 177 reference genome [KT582109 bases 1-18882] using GSNAP (version 2015-09-29) (29) using 178 default settings. 179
Because of the very high coverage in each sample, duplicate reads were not removed, a 180 step usually taken in single nucleotide variant (SNV) analysis. Sorted and indexed BAM files 181 were processed with LoFreq* (version 2.1.2) (30) using default settings, to call SNVs. A final 182 cut-off of ≥0.005 allele frequency was selected as a conservative threshold, calculated as 1.25 183 standard deviations above the mean of each nucleotide's maximum detected allele frequency 184
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Ebola virus adaptive changes in snake cells 9 (0.00339, σ = 0.00129) of the Illumina supplied PhiX control sequence, which was included in 185 each sequencing run. SNVs were then determined to be either synonymous or non-synonymous. 186
Analysis was performed and graphs were generated using Python3, IPython (31), pandas (32), 187 matplotlib (33), and seaborn (34). 188
Testing for selection 189
See supplemental methods. Briefly, we developed a simulation-based procedure to identify 190 alleles in the EBOV genome that changed frequency over passages more than expected under 191 neutrality given the dynamic viral population size and estimated sequencing error rates. The 192 neutral simulations had five parameters: the overall population growth function, the number of 193 generations, the starting allele frequency, and the read depth for each site during the first and last 194
passage. 195
Detection of defective interfering genomes 196
Sequencing reads were processed in the same way as for SNV analysis. For each passage point, 197
only properly paired reads were used. All of the passages of replicate 1 in JK cells (JK-R1) and 198 passage 1, replicate 1, of passage in HeLa cells (HeLa-R1-P1) had a sizable drop in Q-score 199 during sequencing of read 2. These reads were filtered out during pre-processing, necessitating 200 that these paired-end reads be mapped as a combined single-end sample for each of the above 201 passages. These combined samples then lacked proper pairing and were not used in defective 202 interfering (DI) genome analysis. Each of the properly paired reads were also confirmed for the 203 correct mapping orientation. Then the "reference location" located in each samples' BAM file 204 was used as that read's mapping location and the distance difference between the read 1 mapping 205 location and read 2 mapping location was calculated along with the mean and standard deviation 206 for the entire set. Proper pairs characterized by a distance difference greater than the mean + 3 σ 207 were counted as reads coming from potential DI genomes. 208
Data availability 209
Sequencing data from EBOV passaging is located on NBCI SRA under BioProject: 210
PRJNA353512. 211
RESULTS
212
Ebola virus, but not Marburg virus, replicates in boa constrictor cells 213
To test whether filoviruses can replicate in boa constrictor cells, we exposed a previously 214 (Table S2) . At all passages, EBOV infected 246 JK cells revealed clusters of EBOV GP 1,2 -positive cells, with predominantly cytoplasmic and cell 247 membrane staining (Fig. 2) . Over the course of these passages, the number of genome 248 equivalents produced by infected JK cells was modestly lower than by infected HeLa cells. For the data presented here, the lack of a 3′ to 268 5′ coverage gradient is consistent with sequence reads derived from EBOV genomic RNA in cell 269 culture supernatant virions, as opposed to cellular EBOV transcripts (Fig. 3) . 270
These data identify boa constrictor JK cells as susceptible to EBOV, but not MARV, 271 infection. To our knowledge, JK cells represent the first cell line with filovirus genus-specific 272 (ebolavirus vs. marburgvirus) susceptibility to infection. 273
Ebola virus adaption is not required for infection of boa constrictor cells
We first characterized the extent of variation within the EBOV inoculum population. We 275 detected 48 single nucleotide variants (SNVs) in the inoculum that passed our quality and 276 frequency cut-off filters including 21 non-synonymous SNVs. We detected only a single position 277 (nt 7669, EBOV glycoprotein precursor [preGP] codon 544: T544I) with a nonsynonymous SNV 278
having an allele frequency of >10% in the inoculum (Table 1, Table 2 , Fig. 4A ). At this position, 279 the initial population consisted of 62.0% (Thr) and 37.9% (Ile), similar to the previously 280 characterized EBOV/Kik-951061 "R4414" (passage 2) strain (19). 281
We then characterized variation across passages in JK and HeLa cells. Taking into 282 account all replicates and all passages, we detected a mean of 89 SNVs (σ = 31) for passages in 283
HeLa cells and a mean of 51 SNVs (σ = 19) for passages in JK cells Table 1 , Fig. 5A ). 284
Considering only nonsynonymous variants that were not already present in the inoculum, we 285 detected a mean of 15 (σ = 15) for all replicates and all passages in HeLa cells and a mean of 8 286 (σ = 7) for all replicates and all passages in JK cells (Table 1, Fig. 5B ). 287
To determine whether there was a change in the distribution of allele frequencies 288 associated with EBOV SNVs detected as a function of passage or host (boa constrictor vs. 289 human) cell, we focused on a comparison of the first and last EBOV passages. The mean allele 290 frequency associated with non-synonymous SNVs not found in the inoculum for EBOV grown 291 in HeLa cells was 0.009 and 0.015 in in the first passage and passage 6, respectively. The 292 difference between these passages was statistically significant (KS-test, p = 0.00051 < 0.01 293 Holm-Bonferroni adjusted p). However, the difference in distributions of allele frequencies 294 associated with non-synonymous variants not found in the inoculum for EBOV grown in JK cells 295
was not significant (KS-test, p = 0.41710 > 0.01 Holm-Bonferroni adjusted p). 296
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We also compared the distribution of allele frequencies associated with nonsynonymous 297 variants not found in the EBOV inoculum between the two host cells at the last passage. The 298 difference between their means was relatively small (HeLa, JK mean = 0.015, 0.012, 299 respectively), and the difference between these distributions was not statistically significant (KS-300 test, p = 0.0131 > 0.0083 Holm-Bonferroni adjusted p). 301
To further increase the stringency of our criteria for identifying biologically relevant 302 EBOV variants, we considered only non-synonymous variants present in all three biological 303 replicates for each passage from each host cell that were not present, or at a frequency below the 304 limit of detection in the inoculum (Table 1, Fig. 5C ). We detected a mean of 3 non-synonymous 305 SNVs (σ = 2) across all passages in HeLa and a mean of 1 non-synonymous SNVs (σ = 1) across 306 all passages in JK. We were unable to detect any EBOV SNVs that met these criteria for the first 307 passage in either cell type. For JK passages, EBOV SNVs that met these criteria were only 308 detected in passages 3, 4, and 6. In the case of passage 6 we did not find any statistical 309 significance between the distributions of allele frequencies of SNVs found in the HeLa passage 310 vs. the JK passage (KS-test p = 0.4249 vs. 0.05). 311
Finally, we implemented a rigorous simulation-based test for neutral evolution of EBOV 312 that takes into account sequencing error, sampling error, and an estimated demographic model 313 representing the passages in our experiments. We found numerous variants that deviate from 314 neutral expectations (14,473 sites in JK and 15,028 sites in HeLa). However, as discussed above, 315 nearly all of these variants experienced extremely small changes in allele frequency. To estimate 316 the strength of selection operating on EBOV in each cell line, we implemented a deterministic 317 fitness model and applied it to each site in turn. We found that the estimated selection 318 coefficients are small (Fig. 4B, and Table S1 ). 319
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Together, these data indicate that EBOV can replicate in boa constrictor cells for 320 prolonged times/passages without requiring major genomic adaptations. 321
Weak positive selection operates on the Ebola virus genome during passaging 322
To identify EBOV genomic sites undergoing positive selection in JK or HeLa cells, we first 323 excluded sites with total read coverage that was not within two standard deviations of the 324 genome-wide mean (calculated by first averaging the total reads across the three replicates for 325 each passage and then averaging all passages). After filtering, a total of 17,924 sites and 17,970 326 sites, covering 95% of the genome, were retained for EBOV passaged on HeLa and JK cells 327 respectively. Only three EBOV genomic sites had a change in allele frequency of at least 10%, 328 all of which were identified in JK cell-grown virus ( Figure 5C , Table S1 ): nucleotide positions 329 5,780 (located in VP40 5′ UTR), 7,669 (preGP T544I), and 18,016 (L, sysnonymous mutation). 330
In HeLa cells, all allele frequency changes were less than 7% (Table S1 ). Using a deterministic 331 model of positive selection (see supplemental methods), we estimate that the selection 332 coefficient at all sites in the EBOV genome (across both HeLa and JK cells) was less than 12%. 333
These data suggest that weak selection can be identified in the EBOV genome over passages 334 (particularly in JK cells; see supplemental methods for statistical test results), but that very little 335 adaptation is necessary to successfully passage EBOV in either cell type. 336
Passage of Ebola virus in either Boa constrictor cells or HeLa does not lead to appreciable 337 production of defective interfering genomes 338
The presence of DI particles has been noted with EBOV in grivet (Chlorocebus aethiops) kidney 339 epithelial Vero E6 cell culture, but they remain poorly understood with only a single paper 340 published on EBOV DI genome characterization (37). Viral DI particles often contain genomes 341 with long deletions or genomic re-arrangements that presumably arise through errors in 342 replicates. The EBOV inoculum featured 0.0276% of reads that were consistent with internal 346 genomic deletions. We detected a low level of putative deletion sequences in both cell types 347 (0.0780% σ= 0.0535 for HeLa cells and 0.0234% σ= 0.00480 for JK cells) in all passages and 348 replicates distributed across the EBOV genome (Table 1, Fig. S1 ). By the final passage, this 349 value changed to 0.0552% σ= 0.00340 and 0.0206% σ= 0.00185 for HeLa and JK cells, 350
respectively. In this analysis, we can not rule out the possibility of internal deletions produced 351 during sequencing library preparation, and thus these measurements are likely to be over 352 estimates. Regardless, this analysis indicates that sequences consistent with the presence of DI 353 particles could be detected, but only at very low frequencies. 354
DISCUSSION 355
The natural reservoir of EBOV and all other ebolaviruses remains unclear. Marburgviruses have 356 been isolated from wild Ugandan Egyptian rousettes (Rousettus aegyptiacus) and also have been 357 used to infect these bats experimentally (11, 15, 16 3, 40,  370 
41)). 371
In 2001, a possible genetic link between mammalian arenaviruses (family Arenaviridae, 372
genus Mammarenavirus) and the mononegaviral filoviruses was suggested based on similarities 373 between arenaviral and filoviral glycoproteins (17). This possible link was further substantiated 374 by the structural characterization of the glycoprotein from a newly discovered snake 375
reptarenavirus (genus Reptarenavirus) (42). Filoviral glycoproteins engage endosomal 376
mammalian Niemann-Pick disease, type C1 protein (NPC1) to gain entry into host cell (12, 43) . 377
Interestingly, Russell's viper (Daboia russellii) cells do not support EBOV entry and Russell's 378
viper NPC1 does not bind to the EBOV glycoprotein. This deficiency was traced to a single 379 amino acid (Y503) that, when changed to the analogous human residue (Y503F), causes Russel's 380 viper cells to become susceptible to EBOV infection (44). Although the boa constrictor genome 381 has been assembled, it has not been annotated (REF PMID 23870653 ). We used a comparative 382 alignment approach and mapping of transcriptome-derived short sequence reads to predict the 383 boa constrictor NPC1 protein sequence (Genbank XXXXXXX). The predicted boa constrictor 384 NPC1 has an Phe residue at the critical position (F517, homologous to F503 in human NPC1), 385 which is consistent with boa constrictor cell susceptibility to EBOV infection. This supports the 386 possibility that NPC1 from snakes of certain species may have been subject to selection by 387
viruses with filovirus-like glycoproteins (44). 388
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We aimed to further explore the potential genetic link between filoviruses and 389 reptarenaviruses. Reptarenaviruses are known to infect captive boid snakes (pythons and boas) 390 (18, 45-47). We tested whether boa constrictor JK cells are naturally capable of supporting 391 EBOV or MARV infection. While MARV infection was unsuccessful, JK cells supported EBOV 392 replication over six passages in the absence of major genomic adaptation. Only one genomic 393 position, 7669, (EBOV preGP T544I) switched major alleles (38% to 52%). After maturation of 394 the glycoprotein precursor, this residue resides in the preGP cleavage product GP 2 . The residue is 395 a critical structural determinant of the EBOV GP 2 fusion loop, which mediates fusion of the 396 filovirion membrane with the host-cell membrane to initiate virion entry (48). In contrast to the successful infection of JK cells with EBOV, these cells were unable to 406 support productive MARV infection. Uncovering the molecular underpinnings of this difference 407 could increase our understanding of filovirus tropism. Importantly, EBOV infection of JK cells 408 occurred in the absence of CPE, an observation that also has only rarely been reported (53). 409
These observations raise the possibility that ebolaviruses and marburgviruses could sub-410 clinically and/or persistently infect disparate hosts, possibly even of different animal orders (e.g.,mammals vs. reptiles). Additional non-mammalian cell lines should therefore be screened for 412 filovirus susceptibility to aid the search for natural filovirus hosts, possibly followed by 413 experimental animal inoculations or exposures. These experiments further suggest that additional 414 genetic dissection of MARV will reveal the underlying determinants that prevent JK cell 415 infection. 416
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